Deltex Medical Group plc (AIM: DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), is pleased to announce that Andy Mears, the Company’s Chief Executive Officer, will be presenting at an investor evening…
Deltex Medical 2018 Results
Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring, has announced its audited results for the year ended 31 December 2018. Find the link to the…
Pre-Close Statement and Trading Update
Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring, has published a pre-close statement in relation to the year ended 31 December 2018. The Group has…
NICE Recommends ODM in Trauma Patients with Major Haemorrhaging
The UK’s National Institute for Health and Care Excellence (NICE) publishes guidance on many aspects of patient care. These documents are often collated into treatment pathways, bringing together everything NICE…
29 Years and Counting: Mears and the Haemodynamic Management Mission
Speaking from the heart, Andy Mears CEO of Deltex says “Thanks to LinkedIn for kindly pointing out that I am celebrating 29 years at Deltex Medical this month. Thanks also…
Show Time for Deltex with US Launch of TrueVue at ASA
October 13th sees the start of this year’s Anesthesiology Society of America (ASA) annual congress in San Francisco. Deltex will be exhibiting at this major event (booth 1513), launching its…
Journal Spells it Out: Haemodynamic Management Matters
October’s Clinical Services Journal includes an article that should be essential reading for the anaesthetist who wants to deliver optimal care. That’s because it gets down to the bare bones…
Deltex at US Evidence-Based Medicine Show
September 28-30th sees Chicago hosting a Perioperative Care “Practicum” at which Deltex will be participating. The event, advertised as the EBPOM(Evidence-Based Perioperative Medicine)-USA Chicago Masters Course will see thought leaders…
Deltex at AAGBI
The Association of Anaesthetists of Great Britain and Ireland holds its annual congress next week in Dublin, details here. As haemodynamic monitoring technology leader, Deltex will of course be there,…
Improving Safety Through Patient Monitoring
The robust foundation of clinical evidence in support of Deltex Medical’s oesophageal Doppler monitoring (ODM) system has once more attracted press attention. The Clinical Services Journal, a major UK-based monthly…
